36. HAMID MASOUDI
Information acquired: 2025
HAMID MASOUDI is an academic who published a paper in 2008 entitled Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease. HAMID MASOUDI published this work as part of a team: Habibi, Golareh. Here is a description of this work: Introduction: Gene expression analysis is used to subtype breast cancers such that the most aggressive tumors are identified, but translating this into clinical practice can be cumbersome. Our goal is to develop a universal biomarker that distinguishes patients at high risk across all breast cancer subtypes. We previously reported that Y-box binding protein-1 (YB-1), a transcription/translation factor, was a marker of poor prognosis in a cohort of 490 patients with breast cancer, but the study was not large enough to subtype the cancers. We therefore investigated whether YB-1 identifies patients at risk for either reduced relapse free survival or decreased r breast cancer specific survival (BCSS) across all tumor subtypes by evaluating 4,049 cases. Methods: Tumor tissue microarrays, representing 4,049 c.